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Background: Evaluation of pregnant women with known or suspected Crohn’s disease (CD) remains a challenge.
Magnetic Resonance Enterography (MRE) is a promising diagnostic tool in these patients; however, the clinical data
on MRE utilization in pregnancy is scarce. The aim of the study was to describe the experience with MRE in
pregnant CD patients in a tertiary referral center.
Methods: We retrospectively reviewed MRE studies performed in pregnant women with known or suspected CD
that were performed between January 2007 and November 2012. Imaging findings, clinical management and
outcome were extracted from patient’s file and electronic records. Image quality was evaluated.
Results: Ten studies of 9 patients were included. MRE protocol was modified to maximize maternal and fetal safety,
and intravenous gadolinium was not used. In 7 patients, CD diagnosis was previously established; six were admitted
with clinical symptoms consistent with CD exacerbation, and an additional patient with a recurrent groin abscess
without apparent luminal symptoms. In all seven patients, imaging features consistent with active CD were
detected; new penetrating complications were detected in 4 patients. Two patients underwent MRE for suspected
CD which was not comforted by study results. The clinical management was significantly impacted by MRE results
in all positive cases. The image quality of the fast MRE sequences obtained without gadolinium was satisfactory and
allowed meaningful interpretation.
Conclusion: MRE with an adapted protocol for pregnancy is a reliable imaging modality to manage in pregnant
women with known or suspected CD.
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Pregnant women with Crohn’s disease (CD) pose a range
of diagnostic and clinical challenges [1]. When a pregnant
woman presents with a clinical picture consistent with sus-
pected new-onset CD or exacerbation of previously estab-
lished CD, diagnostic options are somewhat limited due to
maternal and fetal safety concerns. Endoscopy can be per-
formed if needed for evaluation of colonic or distal ileal in-
flammation with necessary procedural precautions and
careful selection of a sedation regimen, however, evaluation
of small-bowel disease and penetrating complications usu-
ally requires cross-sectional imaging [2]. Prompt evaluation* Correspondence: ukopylov@gmail.com
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unless otherwise stated.and management are required, as active CD or penetrating
complications carry a significant risk of morbidity such as
preterm delivery and low birth weight [3-6]. Accurate ana-
tomical information and evaluation of CD complications is
mandatory in considering and planning surgical interven-
tion, when necessary, in severely ill patients. Moreover, im-
aging may be valuable in planning the mode of delivery, as
cesarean section is usually recommended in patients with
active perianal disease [5,7].
Both computer tomography enterography (CTE) and
magnetic resonance enterography (MRE) are commonly
used to evaluate disease activity and complications in
CD patients. However, CTE is associated with a signifi-
cant exposure to ionizing radiation potentially harmful
for the fetus [8,9].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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therefore is the preferred cross-sectional diagnostic mo-
dality in pregnancy. However there is a paucity of data
outlining the utilization of MRE in pregnant CD pa-
tients. In particular, safety data pertaining to the intra-
venous contrast material (gadolinium) routinely utilized
in MRE is very limited, and it’s use in pregnancy recom-
mended only when absolutely necessary [10].
Several typical MRE findings reflect disease activity in
CD [11]. Bowel wall thickness, relative contrast enhance-
ment, presence of edema, and mucosal ulcerations have
been shown to be independently correlated with endo-
scopic disease activity. An index incorporating these pa-
rameters (Magnetic resonance index of activity, MaRIA)
was significantly correlated with the Crohn’s Disease
Endoscopic Index of Severity (CDEIS) [12].
An additional MRE scoring system based on mural
thickness and T2 signal intensity was demonstrated to
be significantly correlated with a histological score of the
terminal ileum inflammation [13].
The purpose of the present study is to report our ex-
perience in with MRE utilizing a modified protocol
adapted to maximize patient and fetus safety in the con-
text of suspected CD or CD exacerbation in a tertiary re-
ferral center setting.Methods
Study population
The study cohort included all pregnant patients who
underwent MRE studies for suspected or established CD
between 01/2007-12/2012. Relevant demographic and
clinical data was retrieved from the patient’s files andTable 1 Summary of MRE findings in pregnant patients with
Patient number 1a 1b 2
Mural signs
Small bowel mural thickening + + -
Large bowel mural thickening + + +
Mural high T2 signal + + NA
Stenosis & prestenotic dilatation + + -
Ulcers + + +
Mesenteric signs
Comb sign + + +
Creeping fat + + +
Lymphadenopathy - - +
Complications
Phlegmon + + -
Abscess - + -
Fistula ++ ++ -
Free fluid - - -electronic records. This retrospective study was approved
by ethics review board of Chaim Sheba medical center.
MRE protocol
All MRE studies were performed on a 1.5 T MR
System (General Electric Healthcare, Little Chalfont,
Buckinghamshire, United Kingdom) with an 8 chan-
nels cardiac coil. Our standard MRE protocol was
adapted for pregnant patients. Oral contrast with Man-
itol 5% (1000 ml) was administered 60 minutes prior
to the examination. However, neither Gadolinium che-
late nor glucagon (used to minimize bowel motility)
were administered.
The obtained MRE sequences included:
FIESTA (Fast Imaging Employing Steady State
Acquisition) in axial, coronal and sagittal planes (repetition
time (TR)/echo time (TE) = 4.2-5/1.2-2.3 milliseconds
(ms), slice thickness 6 mm, without interslice gap, field of
view (FOV) of 36–44 cm2, acquisition matrix of 384×384,
number of excitations (NEX) o = 1; flip angle 60°):
FSE (Fast spin Echo) T2 with fat suppression, in axial
and coronal planes (TR/TE =1555-3500/88-93 ms, slice
thickness 6 mm without interslice gap, FOV of 44 cm2,
acquisition matrix of 384×224, NEX =1):
T1 weighted 2D FSPGR (Fast spoiled Gradient Recalled
Acquisition in the Steady State) with fat suppression and
breath hold in axial and coronal planes (TR/TE = 75-155/
1.3-4.2 ms, slice thickness 6 mm, without interslice gap,
FOV of 36 cm2, acquisition matrix of 512×256, NEX =1,
flip angle 75°).
T1 weighted 3D LAVA (Liver Acquisition with Volume
Acceleration) (without contrast) with fat suppressionknown (1–7) or suspected CD (8, 9), NA: not available
3 4 5 6 7 8 9
- + - + + - -
- - + + + - +
NA + NA + + - NA
- + + + + - +
- + + + + - +
+ + + + + - -
+ + + + - - -
- + - + + + -
- + - + + - -
- - - - - - -
- + - + - - -
- - - + - - -
Stern et al. BMC Gastroenterology 2014, 14:146 Page 3 of 9
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3.6-4.3/1.7-2.1 ms, coronal: slice thickness 4 mm, no
interslice, axial: slice thickness 6 mm and overlap of
3 mm, FOV of 44 cm2, acquisition matrix of
416-320*192, NEX =0.75, flip angle 15°).Figure 2 A 20 weeks pregnant patient with CD, Coronal FIESTA:
signs of active disease: small bowel mural thickening and ulcer
(arrow), note free fluid (dashed arrow).Analysis of MRE findings
MRE studies were reviewed by two experienced abdominal
radiologists (MMA, SA) for signs of active and chronic
CD and extraluminal complications. The main recorded
findings included:
Mural findings: mural thickening of 3 mm or more,
ulcerations, wall edema (high T2 signal on FSE
sequence), luminal stenosis, prestenotic dilatation.
Mesenteric findings: congestion (comb sign), hypertrophy
(creeping fat), and lymphadenopathy. (lymph node
shortest diameter > 10 mm).
Extra luminal findings: phlegmon, abscess, fistula, free fluid.
Bowel obstruction, bowel perforation or acute hemorrhage
were considered as findings requiring urgent surgical
attention.Image quality assessment
The image quality of each sequence for every MRE study
was evaluated using a score varying from poor to good
(1–3): 1 = blurred image, 2 = fairly satisfactory image, 3 =Figure 1 A 19 weeks pregnant patient with CD, Coronal FIESTA:
signs of active disease: mesenteric congestion (arrow) and
large bowel mural thickening and edema (dotted arrow).clear image. A mean score was obtained for each sequence
by both reviewers.
The clinical course and outcomes of the included pa-
tients was described.
Results
The study population included nine pregnant CD pa-
tients who underwent a total of ten MRE studies. The
indications for MRE studies were as follows:
Clinical exacerbation of known CD (n = 7), including
exacerbation of luminal disease in 6 patients (in one ac-
companied by a new-onset cholestasis and in another
one- by preeclampsia) and a recurrent groin abscess in
one patient; suspected CD (n = 2).
The demonstrated MRE findings for each patient are
described in detail in Table 1. In all patients with knownTable 2 Sequences quality score of MRE protocol adapted
to pregnancy




Fast SE T2 coronal 2.8
Fast SE T2 axial 2.2
FSPGR 2D T1 coronal + fat sat 1.6
FSPGR 2D T1axial + fat sat 1.5
LAVA 3D T1 coronal + fat sat 1.6
LAVA 3D T1 axial + fat sat 2
FIESTA- Fast Imaging Employing Steady State Acquisition.
SE-spin echo.
FSPGR- Fast spoiled Gradient Recalled Acquisition in the Steady State.
LAVA- Liver Acquisition with Volume Acceleration.
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UC-ulcerative colitis, VD- vaginal delivery, RQ-right lower quadrant, 6-mp- 6-mercaptopurine, UDCA-ursodeoxycholic acid.
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strated on MRE. Wall thickening and ulcers were dem-
onstrated in 6 patients (86%), high T2 signal in bowel
wall in 4/4 patients who had T2 sequences performed,
phlegmon in 4/7 (57%) and abscess in 1/7 (14%). Positive
comb sign (a hallmark of mesenteric inflammation) was
demonstrated in all patients. Fistulae were seen in 3
(43%), while stenosis and prestenotic dilatation were
seen in 5 (71%).
In two patients, MRE was performed for clinical suspi-
cion of CD. In one patient, no radiological findings com-
patible with this diagnosis were demonstrated. The
second patient was diagnosed with ulcerative colitis in
the past. Her study demonstrated colonic findings com-
patible with UC and not CD (large bowel mural thicken-
ing, submucosal edema).
The typical radiographic signs of active CD identified on
our modified protocol for pregnancy included mural thick-
ening of 3 mm or more, ulcers, wall edema, comb sign,
phlegmon, abscess and fistula are presented in Figures 1
and 2.Image quality assessment
FIESTA sequences were of very good quality and en-
abled accurate assessment of the bowel anatomy, as well
as the presence of a phlegmon, an abscess or free fluid.
The images did not have significant motion artifacts.
Fast spin echo T2 sequences, although not available
for all patients, were useful for evaluation of edematous
bowel loops and in ruling out the presence of free fluid.
Gradient echo (GRE) T1 weighted 3D LAVA sequences
were blurred by motion artifacts. GRE T1 weighted 2D
FSPGR had motion artifacts and their added diagnostic
value was relatively low. Coronal planes were easier to
interpret than axial planes (Table 2).Clinical impact of the MRE findings
In all the 9 patients, MRE findings have contributed useful
clinical information and impacted the clinical management
(Table 3). The findings of the MRE were valuable in ruling
out the diagnosis in the two patients suspected of CD: one
patient (n°8) had no radiological findings suggesting CD
and did not require anti-inflammatory treatment. In the
other patient, the diagnosis of UC was confirmed and CD
was ruled out, as no signs of small bowel or mesenteric dis-
ease and no penetrating complications were demonstrated
(Figure 3).
In all patients with known CD, no complications re-
quiring emergent surgical interventions such as obstruc-
tion, perforation or hemorrhage were demonstrated. The
patients were treated conservatively and did not require
surgical intervention prior to the delivery.
Extraluminal complications such as phlegmon, abscess,
fistula, free fluid were ruled out in 3 patients (n°2,3,5). In
one patient with preeclampsia (n°5), MRE was performed
one day before delivery, and assisted the decision to per-
form a cesarean section approach since no intra-abdominal
complications were detected. In two others (n°2 & 3), med-
ical treatment was adjusted with good response of CD
symptoms.
In four patients (n°1,4,6,7), extraluminal complications
were newly diagnosed by MRE .In one of them (n°1) the
visualization of a phlegmon transforming into an abscess,
inaccessible for drainage, was detected on a second MRE
examination, and impacted a physician decision to under-
take a surgical intervention after a spontaneous vaginal
delivery at 34 weeks. MRE findings were confirmed during
surgery (Figure 4).
In patient n°4, phlegmon and fistula were demon-
strated. A partial clinical response was obtained with
intravenous antibiotics until spontaneous vaginal deliv-
ery at 38 weeks. Due to persistence of the clinical
Figure 3 A 11 weeks pregnant patient diagnosed with UC, a: Coronal FIESTA, large bowel mural thickening with a thumb printing
pattern (arrow), b: Coronal FIESTA, ileo-cecal stenosis (arrow), c: Axial SSFSE T2 submucosal edema (arrow).
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delivery CT was performed, which confirmed the MR
findings.
Patient n°6 presented with a recurrent groin abscess that
required multiple drainage procedures, without clinical ex-
acerbation of the luminal disease. An MRE was performed
at week 12 of pregnancy. The study demonstrated active
disease in terminal ileum and cecum accompanied by a
phlegmon and a new inflammatory tract communicating
to another phlegmonous subcutaneous zone correspond-
ing to the location of the drained abscess.
In the fourth patient (n°7) who presented with CD ex-
acerbation, cervical widening and early contractions at
17 week of pregnancy, a phlegmon was demonstrated.
The patient did not respond to medical treatment, and
spontaneus delivery occurred at 28 week. On presen-
tation this patient was treated with a combination of
6-mercaptopurine and adalimumab. There is no clear
evidence to suggest that a combination of adalimumab
with a thiopurine is superior to adalimumab alone in CD
(as opposed to Infliximab where such benefit was clearly
demonstrated [14]) and pregnancy-related data are even
more limited.Figure 4 A pregnant patient with CD at 23 weeks (a) and 26 weeks (b
tracts (arrow), b: Axial heavily weighted T2, abscess near confluenceDiscussion
MRE has long been established as an accurate and safe
modality for diagnosis of CD, monitoring of disease ac-
tivity and detection of complications [2]. In our series, it
appears that, despite the technical limitations (mainly
caused by avoidance of intravenous contrast material
and by motion artifacts), MRE was able to demonstrate
significant and clinically relevant findings impacting the
clinical management in pregnant patients. Important
classical stigmata of CD were demonstrated and con-
firmed on subsequent studies in some of the patients;
non-emergent surgical procedures were deferred until
after delivery and additional clinical decisions such as
mode and timing of planned delivery were impacted by
MRE. Thus, the information provided by MRE plays a
key role in the clinical and surgical management of the
patients.
To the best of our knowledge, our study is the largest
case series describing the utility of MRE in pregnant CD
patients published to date. In addition, in our series we
have utilized oral contrast material, which has not been
reported in pregnant CD patients in current literature.
In an early article, Shoenut et al. [15] reported two cases) of pregnancy: a: Coronal FIESTA fistula (dotted arrow) and sinus
of sinus tract in the same patient three weeks later (arrow).
Figure 5 The impact of an enlarged uterus; a: a 37 weeks pregnant CD patient: Axial FSPGR 2D, pseudo stenosis caused by compressing
uterus, b: a 26 weeks pregnant patient: Coronal LAVA, sigma displaced cranially (not to be misinterpreted as transverse colon above) (arrow).
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without oral contrast material but with Gadolinium in-
jection. Mural thickening and enhancement of the ter-
minal ileum were consistent with CD and subsequently
histologically confirmed [15]. Other studies have been
reported where MR imaging was used for the triage of
pregnant women presenting with acute abdominal pain.
Oto et al. described their experience with MR imaging
of 4 pregnant patients with known CD and exacerbation
[16]. The advantage of gadolinium-enhanced MR im-
aging in pregnant patients with acute abdominal pain
was also reported by Bichard and colleagues in one case
of CD in a series of 29 pregnant patients with acute ab-
dominal pain showed free fluid in the abdomen, thicken-
ing of bowel walls, and diffuse enhancement of the
peritoneum [17]. In contrast to our studies, these reports
have focused on patients with emergent clinical presenta-
tions, and employed different protocols aimed at detection
of urgent surgical complications , as opposed to a dedi-
cated MRE protocol that is optimized for evaluation of
signs of luminal and extraluminal disease activity in CD.
Moreover, in the described studies CD patients were a mi-
nority within a patient cohort that included patients evalu-
ated for multiple urgent indications.Figure 6 A 37 weeks pregnant patient a: Axial FSPGR, wall thickening
by comparing with previous MRE a year earlier, b: Axial LAVA post GInterpretation of MRE in pregnancy presents particu-
lar challenges. The first difficulty is related to anatomical
changes caused by the enlarged uterus, such as pseudo-
stenosis and bowel loop displacement. The sigmoid
colon may appear stenosed due to pressure of the uterus
(see Figure 5a). Another possible anatomical change is
the upward move of the sigmoid colon cranial to the
uterus as presented in Figure 5, where the sigma was ini-
tially misinterpreted as the transverse colon.
An additional challenge stems from a significant de-
crease in image quality due to motion artifacts caused by
fetal movements, difficulty in breath holding and bowel
motion resulting from the omission of glucagon injec-
tion in the modified protocol. Motion artifacts may be
partially overcome with fast acquired sequences such as
FIESTA which produced the highest quality images in
our study. An additional complexity results from non-
utilization of gadolinium, preventing the clear de-
monstration of the wall enhancement. For instance, in
Figure 6a the wall thickening, initially overlooked, was
seen only after comparison with a previous MRE study
(Figure 6b) with gadolinium injection performed prior
to pregnancy. The use of gadolinium in pregnancy is de-
batable. Although no adverse effects to the fetus haveof terminal ileum overlooked (arrow) but retrospectively seen
adolinium injection (arrow) same patient a year earlier.
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College of Radiology recommends its use only when there
is an outstanding benefit [10].
Nevertheless, we administer an oral contrast agent
(mannitol 5%) as normally used in enterography and
enteroclysis, which we believe to be essential for evaluat-
ing bowel loop anatomy. Mannitol is a pregnancy class C
agent, with no evidence of a detrimental effect on fetal
health and development.
The limitation of this study is the small patient group
and the retrospective nature of the study. Nevertheless,
despite the fact that MRE examinations were performed
in sub-optimal conditions with an adapted MRE protocol
maximizing maternal and fetal safety, the results were
clinically useful and accurate .Our results can also be com-
pared to recent studies using diffusion weighted sequences
that provide adequate visualisation of the affected bowel
loops in pediatric patients activity without the need for
intravenous administration of contrast medium [18]. Dif-
fusion weighted sequences are currently performed in
pregnant women for fetal or abdominal evaluation, al-
though they are prone to movement artifacts and their
safety has not been evaluated in pregnancy; these se-
quences were not performed in our standard protocol but
could be added in future evaluation.
Radiological limitations did not hamper the clinical
utility of our MRE studies, which proved to be very use-
ful in managing the patients and also concurred with the
clinical outcome. Nonetheless, further larger studies are
pertinent in order to establish the exact role of MRE in
the management of Crohn’s patients during pregnancy.
Conclusion
In conclusion, modified MRE sequencing provided ac-
curate and clinically meaningful results in our series.
MRE studies with an adapted protocol for pregnancy are
useful in establishing disease activity and diagnosis of
complications in pregnant patients with Crohn’s disease
and helped to rule out CD in pregnant patients.
Abbreviations
MRE: Magnetic resonance enterography; CD: Crohn’s disease; UC: Ulcerative
colitis.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MDS conceived of the study, and participated in its design, carried out the
studies, data analyses and drafted the manuscript. SB provided and drafted
medical data. UK drafted and reviewed the manuscript. SA participated in
the design of the study and helped to draft the manuscript. MMA conceived
of the study, coordinated it, participated in its design, provided imaging data
and analysis and helped to draft the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
We would like to thank Professor Marjory Hertz for reading the manuscript
and correcting it with helpful remarks.Author details
1Department of Diagnostic Imaging, Sheba Medical Center, Ramat Gan,
Israel. 2Department of Gastroenterology, Sheba Medical Center, Ramat Gan,
Israel.
Received: 11 March 2014 Accepted: 13 August 2014
Published: 16 August 2014
References
1. Beaulieu DB, Kane S: Inflammatory bowel disease in pregnancy. World J
Gastroenterol 2011, 17:2696.
2. Panes J, Bouhnik Y, Reinisch W, Stoker J, Taylor SA, Baumgart DC, Danese S,
Halligan S, Marincek B, Matos C, Peyrin-Biroulet L, Rimola J, Rogler G, van Assche
G, Ardizzone S, Ba-Ssalamah A, Bali MA, Bellini D, Biancone L, Castiglione F,
Ehehalt R, Grassi R, Kucharzik T, Maccioni F, Maconi G, Magro F, Martín-Comín J,
Morana G, Pendsé D, Sebastian S, et al: Imaging techniques for assessment of
inflammatory bowel disease: joint ECCO and ESGAR evidence-based
consensus guidelines. J Crohn’s Colitis 2013, 7:556–585.
3. Beniada A, Benoist G, Maurel J, Dreyfus M: Inflammatory bowel disease
and pregnancy: report of 76 cases and review of the literature. J Gynecol
Obstet Biol Reprod 2005, 34:581–588.
4. Bortoli A, Pedersen N, Duricova D, D'Inca R, Gionchetti P, Panelli MR,
Ardizzone S, Sanroman AL, Gisbert JP, Arena I, Riegler G, Marrollo M,
Valpiani D, Corbellini A, Segato S, Castiglione F, Munkholm P, European
Crohn-Colitis Organisation (ECCO) Study Group of Epidemiologic
Committee (EpiCom): Pregnancy outcome in inflammatory bowel disease:
prospective European case‐control ECCO‐EpiCom study, 2003–2006.
Aliment Pharmacol Ther 2011, 34:724–734.
5. Caprilli R, Gassull MA, Escher JC, Moser G, Munkholm P, Forbes A, Hommes
DW, Lochs H, Angelucci E, Cocco A, Vucelic B, Hildebrand H, Kolacek S, Riis
L, Lukas M, de Franchis R, Hamilton M, Jantschek G, Michetti P, O'Morain C,
Anwar MM, Freitas JL, Mouzas IA, Baert F, Mitchell R, Hawkey CJ: European
evidence based consensus on the diagnosis and management of
Crohn’s disease: special situations. Gut 2006, 55:i36–i58.
6. Smink M, Lotgering F, Albers L, de Jong D: Effect of childbirth on the
course of Crohn’s disease; results from a retrospective cohort study in
the Netherlands. BMC Gastroenterol 2011, 11:6.
7. Ilnyckyj A, Blanchard JF, Rawsthorne P, Bernstein CN: Perianal Crohn’s
disease and pregnancy: role of the mode of delivery. Am J Gastroenterol
1999, 94:3274–3278.
8. Brenner DJ, Doll R, Goodhead DT, Hall EJ, Land CE, Little JB, Lubin JH, Preston DL,
Preston RJ, Puskin JS, Ron E, Sachs RK, Samet JM, Setlow RB, Zaider M: Cancer
risks attributable to low doses of ionizing radiation: assessing what we really
know. Proc Natl Acad Sci U S A 2003, 100:13761–13766.
9. Amitai MM, Ben-Horin S, Eliakim R, Kopylov U: Magnetic resonance
enterography in Crohn’s disease: a guide to common imaging
manifestations for the IBD physician. J Crohn’s Colitis 2013, 7:603–615.
10. Kanal E, Barkovich AJ, Bell C, Borgstede JP, Bradley WG Jr, Froelich JW, Gilk T,
Gimbel JR, Gosbee J, Kuhni-Kaminski E, Lester JW Jr, Nyenhuis J, Parag Y,
Schaefer DJ, Sebek-Scoumis EA, Weinreb J, Zaremba LA, Wilcox P, Lucey L,
Sass N: ACR guidance document for safe MR practices: 2007.
Am J Roentgenol 2007, 188:1447–1474.
11. Ziech ML, Bossuyt PM, Laghi A, Lauenstein TC, Taylor SA, Stoker J: Grading
luminal Crohn’s disease: which MRI features are considered as
important? Eur J Radiol 2012, 81:e467–e472.
12. Rimola J, Ordás I, Rodriguez S, García-Bosch O, Aceituno M, Llach J, Ayuso C,
Ricart E, Panés J: Magnetic resonance imaging for evaluation of Crohn’s
disease: validation of parameters of severity and quantitative index of
activity. Inflamm Bowel Dis 2011, 17:1759–1768.
13. Steward MJ, Punwani S, Proctor I, Adjei-Gyamfi Y, Chatterjee F, Bloom S,
Novelli M, Halligan S, Rodriguez-Justo M, Taylor SA: Non-perforating small
bowel Crohn’s disease assessed by MRI enterography: derivation and
histopathological validation of an MR-based activity index. Eur J Radiol
2012, 81:2080–2088.
14. Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A,
Rachmilewitz D, Lichtiger S, D'Haens G, Diamond RH, Broussard DL, Tang KL,
van der Woude CJ, Rutgeerts P: Infliximab, azathioprine, or combination
therapy for Crohn’s disease. N Engl J Med 2010, 362:1383–1395.
15. Shoenut JP, Semelka RC, Silverman R, Yaffe CS, Micflikier AB: MRI in the
diagnosis of Crohn’s disease in two pregnant women. J Clin Gastroenterol
1993, 17:244–247.
Stern et al. BMC Gastroenterology 2014, 14:146 Page 9 of 9
http://www.biomedcentral.com/1471-230X/14/14616. Oto A, Ernst RD, Ghulmiyyah LM, Nishino TK, Hughes D, Chaljub G, Saade G:
MR imaging in the triage of pregnant patients with acute abdominal
and pelvic pain. Abdom Imaging 2009, 34:243–250.
17. Birchard KR, Brown MA, Hyslop WB, Firat Z, Semelka RC: MRI of acute
abdominal and pelvic pain in pregnant patients. Am J Roentgenol 2005,
184:452–458.
18. Neubauer H, Pabst T, Dick A, Machann W, Evangelista L, Wirth C, Köstler H,
Hahn D, Beer M: Small-bowel MRI in children and young adults with
Crohn disease: retrospective head-to-head comparison of contrast-
enhanced and diffusion-weighted MRI. Pediatr Radiol 2013, 43:103–114.
doi:10.1186/1471-230X-14-146
Cite this article as: Stern et al.: Magnetic resonance enterography in
pregnant women with Crohn’s disease: case series and literature review.
BMC Gastroenterology 2014 14:146.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
